Ownership history in Squarepoint Ops LLC · 23 quarters on record
This page tracks every 13F SEC filing in which Squarepoint Ops LLC reported a position in APELLIS PHARMACEUTICALS INC (APLS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 192,156 | +139,322 | +263.7% | 0.01% | $4.8M | $25.12 |
| 2025 Q3 | ADDED | 52,834 | +25,834 | +95.7% | 0.00% | $1.2M | $22.63 |
| 2025 Q3 | REDUCED | 27,000 | -302,392 | -91.8% | 0.00% | $611K | $22.63 |
| 2025 Q2 | REDUCED | 329,392 | -113,401 | -25.6% | 0.01% | $5.7M | $17.31 |
| 2025 Q1 | ADDED | 442,793 | +275,831 | +165.2% | 0.01% | $9.7M | $21.87 |
| 2024 Q4 | ADDED | 166,962 | +76,621 | +84.8% | 0.01% | $5.3M | $31.91 |
| 2024 Q3 | ADDED | 90,341 | +29,083 | +47.5% | 0.00% | $2.6M | $28.84 |
| 2024 Q2 | ADDED | 61,258 | +46,258 | +308.4% | 0.00% | $2.3M | $38.36 |
| 2023 Q4 | UNCHANGED | 15,000 | — | 0% | 0.00% | $898K | $59.86 |
| 2023 Q4 | REDUCED | 15,000 | -86,085 | -85.2% | 0.00% | $898K | $59.86 |
As of 2025 Q4 — sorted by position size